Weight at birth and other factors influencing progression of idiopathic membranous nephropathy.

R. Duncan,P. Bass,P. Garrett,J. Dathan

DOI: https://doi.org/10.1093/ndt/9.7.875a

Abstract:

What problem does this paper attempt to address?

Iron Metabolism Before Allo-Hsct in Patients with Acute Leukemia and Impact of Iron Overload on Transplantation

Jimin Shi,Xuying Pei,Yi Luo,Yamin Tan,Yanmin Zhao,Jingsong He,Weiyan Zheng,Xiaoyu Lai,Gaofeng Zheng,Jie Zhang,Maofang Lin,Zhen Cai,He Huang

DOI: https://doi.org/10.1182/blood.v128.22.2461.2461

IF: 20.3

2016-01-01

Blood

Abstract:Abstract Objective: Iron overload is common in patients with acute leukemia who undergoing allogenic hematopoietic stem cell transplantation (allo-HSCT). We performed a comprehensive analysis of iron parameters to assess these patients' iron metabolism, and studied the prognostic impact of pretransplant iron overload on the outcome of transplantation. Methods: In this retrospective study, we studied 124 patients undergoing myeloablative allo-HSCT between 2012 and 2014. Serum iron (SI), serum ferritin (SF), hepcidin (Hepc) and soluble transferrin receptor (sTfR) were measured before transplant. We analyzed the effect of elevated pretransplant ferritin on acute graft versus host disease (aGVHD), infectious complications, overall survival (OS) and non-relapse mortality (NRM). Results: Date of 124 patients (including 56 cases of acute lymphocytic leukemia and 68 cases of acute myeloid leukemia) were analyzed. Median SI, SF, Hepc and sTfR values were 12.15 umol/L, 667.05 ng/ml, 369.50 ng/L and 7.69 ng/ml, respectively. Iron overload (defined as SF>1000 ng/ml) were observed in 27.42% of patients. Pretransplant iron overload was significantly associated with increased risk of bacterial infections during the early post-transplant period, and with reduced risk of aGVHD. Pretransplant iron overload increased NRM and reduced OS, but there were no significant differences. Conclusion: Patients with acute leukemia regularly develop iron overload before they undergoing allo-HSCT. Pretransplant iron overload was correlated with transplantation outcome. Disclosures No relevant conflicts of interest to declare.
Serem Ferritin Was the Only Prognostic Factor for Disease Free Survival in Mds Patients after Allo-Hsct: A Single Centre Study

Jimin Shi,Yi Luo,Yamin Tan,Yu Lin,Zhen Cai,Maofang Lin,He Huang

DOI: https://doi.org/10.1182/blood.v124.21.5859.5859

IF: 20.3

2014-01-01

Blood

Abstract:Abstract Introduction: Myelodysplastic syndrome (MDS) represents a heterogeneous group of hematopoietic stem cell disorders characterized by single-lineage or multi-lineage cytopenias and a risk of progression to acute myeloid leukemia (AML). Despite the development of new drugs, allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only potential curative therapy. We have a retrospective analysis of the efficacy and security of the allo-HSCT therapy for MDS in our singal centre. Method: Between June1999 and March 2012, 39 MDS patients with a median age of 32 years (range, 12-52) were transplanted with a matched related donor (n=10), unrelated donor (n=20) or haploidentical donor (n=9) in our centre. Of the patients, 62% were male; 44% had intermediate-1 risk, 13% intermediate-2 risk and 43% poor risk cytogenetics by the International Prognostic Scoring System criteria. The cell source was bone marrow (BM) in 36%, peripheral blood (PB) in 59% and BM+PB in 5%. 51% patients had received chemotherapy prior HSCT. Conditioning regimens were BUCY or BUCY plus ATG for matched related HSCT and unrelated transplants, AraC+BuCy+ATG+MeCCNU for haploidentical transplants. The median number of CD34+ cells/kg infusion was 5.52×106(range, 0.8×106-10.38×106).Graft-versus-host disease prophylaxis was employed by cyclosporine A (CsA), mycophenolate mofetil (MMF) and short-term methotrexate (MTX). 25 patients received serum ferritin measurement berore HSCT. The mediun level of serum ferritin was 1100ng/ml (range, 456-2318). Result: The median follow-up was 27 months(range,1.5-154). The 3-year disease free survival(DFS) was 60.8%. Transplant related mortality(TRM) was assessed at 37% on the whole cohort. 5% has no engraftment for a total of 2 patients. A neutrophil count of >0.5 × 109/L was achieved at a median of 12 days (range, 9–24 days) and a platelet count of >20 × 109/L within 14 days (9–49 days) post-transplant. Acute GVDH grade 1-2 was documented in 49%, grade 3-4 in 5% and no GVDH in 46%. Chronic GVHD could be identified in 27 patients (69%), 5 of whom had extensive disease, while the other 22 had limited disease. Overall 14 patients (36%) died. Causes of death were Infection 57%,GVDH 8%, haemorrhage 14%, engraft failure 14% and “other causes” 7%. Only one patients died because of relapse of the disease.DFS according to donor source (matched related donor 87.5%, unrelated donor 51.6% and haploidentical donor 55.6%) was not significant (p =0.22 ). Likewise no significant difference was found on DFS among BM 57%, PB 66.4% and BM+PB 50% (p =0.65). A similar DFS was seen in different risk categories (56.7% in intermediate, 66.7% in high-risk; p=0.51). No difference was seen in DFS according to the CD34+ cell number and whether received chemotherapy prior to HSCT. Only the elevated serum ferritin is associated with inferior DFS after HSCT(p =0.018 ). Disclosures No relevant conflicts of interest to declare.
Hepatic iron overload and fibrosis in patients with beta thalassemia major after hematopoietic stem cell transplantation: A pilot study

Ardeshir Ghavamzadeh,Mehrzad Mirzania,Naser Kamalian,Nahid Sedighi,Parisima Azimi

2015-04-01

Abstract:Currently, hematopoietic stem cell transplantation (HSCT) is the only curative option for patients with beta-thalassemia major, but liver iron overload in these patients will not decrease and hepatic fibrosis may still progress despite successful HSCT. Liver biopsy samples were taken from 14 patients (Out of 25 patients) who underwent HSCT. All patients met three criteria: negative HCV antibody, liver fibrosis in samples before HSCT and lack of regular treatment for iron overload after HSCT (Because patients did not consent to phlebotomy or they had not regular follow-up). We evaluated liver fibrosis and liver iron overload by a semi quantitative method, Perls' Prussian blue staining, before and after HSCT. HSCT was successful in all the patients. Liver iron overload did not change after transplant (P=0.61), but hepatic fibrosis progressed after transplant (P=0.01). In patients with beta thalassemia major who previously had some degree of liver fibrosis, HSCT alone cannot reduce liver iron overload and liver fibrosis will increase. We recommend that regardless of the amount of iron overload in patients with beta thalassemia major that have shown some degree of fibrosis in their liver biopsy before transplantation, appropriate steps should be taken to reduce iron overload as soon as possible after successful transplantation.
Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT)

D Maira,E Cassinerio,A Marcon,M Mancarella,M Fraquelli,P Pedrotti,M D Cappellini

DOI: https://doi.org/10.1007/s00277-017-3120-9

Abstract:A substantial proportion of patients with transfusion-dependent beta-thalassemia major suffer from chronic liver disease. Iron overload resulting from repeated transfusions and HCV infection has been implicated in the development of liver fibrosis. Hepatic siderosis and fibrosis were assessed in 99 transfusion-dependent thalassemia (TDT) patients using transient elastography (TE) and liver iron concentration (LIC) assessed by T2*MRI at baseline and after 4 years. Data were analyzed retrospectively. At baseline, the overall mean liver stiffness measurement (LSM) was 7.4 ± 3.2 kPa and the mean LIC was 4.81 ± 3.82 mg/g dw (n = 99). Data available at 4 ± 1.5 years showed a significant reduction in LSM (6.6 ± 3.2 kPa, p 0.017) and hepatic siderosis measured by LIC (3.65 ± 3.45 mg/g dw, p 0.001). This result was confirmed when considering patients with iron overload at the time of the first measurement (n = 41) and subjects treated with a stable dose of deferasirox over the entire period of observation (n = 39). A reduction of LSM, yet not statistically significant, was achieved in patients on combined deferoxamine + deferiprone, while the group on deferoxamine (n = 11) remained stable over time. HCV-RNA positivity was found in 33 patients at T0, 20 of which were treated during the observation period. Patients who underwent anti-HCV therapy showed a more evident reduction in LSM (9 ± 3 vs 7 ± 3.1 kPa, p 0.016). Adequate chelation therapy is mandatory in order to prevent liver disease progression in TDT. Patients could benefit from regular non-invasive assessment of liver fibrosis by TE to indirectly monitor treatment adequacy and therapeutic compliance.
The effect of bone marrow-derived mesenchymal stem cell co-transplantation with hematopoietic stem cells on liver fibrosis alleviation and survival in patients with class III β-thalassemia major

Tahereh Rostami,Amir Kasaeian,Nasrollah Maleki,Mohsen Nikbakht,Azadeh Kiumarsi,Seyed Mohammad Tavangar,Amir Pejman Hashemi Taheri,Seied Asadollah Mousavi,Ardeshir Ghavamzadeh

DOI: https://doi.org/10.1186/s13287-021-02242-8

2021-03-29

Abstract:Background: Hepatic fibrosis is a common complication in transfusion-dependent thalassemia patients. Data on the co-transplantation of mesenchymal stem cells (MSCs) with hematopoietic stem cells (HSCs) in beta-thalassemia major patients are scarce. Therefore, we aimed to evaluate the effect of co-transplantation of bone marrow-derived MSC with HSCs on the liver fibrosis alleviation and transplant outcomes in class III beta-thalassemia major. Methods: Between April 1998 and January 2017, a total of 224 consecutive patients with class III beta-thalassemia major underwent allogeneic HSCT in the Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran. To assess liver fibrotic changes after transplantation, 47 patients participated in the MSC plus HSC group and 30 patients in the HSC only group at the end of the follow-up period. All patients underwent laboratory tests, especially serum ferritin and liver function testing, hepatic T2* MRI, liver biopsy, and FibroScan before and 2 years after transplantation. Kaplan-Meier curves were derived to determine survival and were compared using the log-rank test. Repeated-measure, mixed-effect linear regression models were used to examine the changes in liver fibrosis over time. Results: The 10-year OS rate was 71.84% in the mesenchymal group and 61.89% in the non-mesenchymal group (P value = 0.294), while the 10-year TFS rate was 63.64% in the mesenchymal group and 52.78% in the non-mesenchymal group (P value = 0.285). No significant difference was observed in the 10-year NRM, rejection rate, ANC engraftment, platelet engraftment, acute GvHD, and chronic GvHD between the two groups. In addition, the results of repeated-measure, mixed-effect linear regression models showed that none of the variables determining hepatic fibrosis had a significant difference between patients receiving MSCs and patients who did not receive MSCs. Conclusions: Based on the results of this study, a single infusion of MSCs at the time of HSCT to patients with class III beta-thalassemia major could not significantly improve the liver fibrosis alleviation and transplantation outcomes, including OS, TFS, TRM, rejection rate, ANC engraftment, platelet engraftment, acute GvHD, and chronic GvHD.
Association between Transfusion-Related Iron Overload and Liver Fibrosis in Survivors of Pediatric Leukemia: A Cross-Sectional Study

Mahsa Sobhani,Naser Honar,Mohammadreza Fattahi,Sezaneh Haghpanah,Nader Shakibazad,Mohammadreza Bordbar

DOI: https://doi.org/10.5223/pghn.2024.27.4.215

Abstract:Purpose: Patients who receive frequent blood transfusions are at an elevated risk of developing hepatic fibrosis due to iron overload in the liver. In this study, we evaluated the effectiveness of transient elastography (TE) (FibroScan®) for assessing liver fibrosis in patients with pediatric cancer. Methods: We enrolled 106 consecutive cases of acute leukemia in individuals under 21 years of age. The participants were followed for 2 years. Based on their serum ferritin (SF) levels, the patients were divided into two groups: group 1 (SF≥300 ng/mL) and group 2 (SF<300 ng/mL). A liver FibroScan® was performed, and a p-value of less than 0.05 was considered statistically significant. Results: Among the various parameters in the liver function test (LFT), alkaline phosphatase was significantly higher in a subgroup of patients aged 5-8 years in group 2 compared to those in group 1. The indices of liver fibrosis determined by TE, including the FibroScan score, controlled attenuation parameter score, steatosis percentage, and meta-analysis of histological data in viral hepatitis score, as well as indirect serum markers of liver fibrosis such as the aminotransferase (AST)/alanine aminotransferase (ALT) ratio, Fibrosis 4 score, and AST to platelet ratio index, did not differ significantly between the two groups. The association between the TE results and LFT parameters was only significant for ALT. Conclusion: Transfusion-associated iron overload does not have a significant correlation with severe liver fibrosis. FibroScan® is not a sensitive tool for detecting early stages of fibrosis in survivors of pediatric leukemia.
Association of serum ferritin trends with liver enzyme patterns in β-thalassemia major: A longitudinal correlational study

Samarth Mukesh Rabadiya,M Yogesh,Jay Nagda,Rohankumar Gandhi,Naresh Makwana

DOI: https://doi.org/10.4103/jfmpc.jfmpc_1897_23

Abstract:Background: β-Thalassemia major patients require lifelong blood transfusions, leading to iron overload and liver injury. This study examines the longitudinal association between serum ferritin and liver function over 5 years in pediatric patients. Methods: This retrospective study included 582 transfusion-dependent thalassemia patients aged 1-18 years. Serum ferritin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and albumin were measured annually. Correlation and linear regression analyses assessed associations between ferritin trajectories and liver enzymes. Results: Mean ferritin rose from 1820 ± 960 ng/mL at baseline to 4500 ± 1900 ng/mL at year 5, indicating worsening iron overload. AST and ALT levels also steadily climbed over follow-up, whereas albumin declined slightly. Ferritin correlated positively with AST (r = 0.675, P < 0.01) and ALT (r = 0.607, P < 0.01), but not with albumin (r = -0.143, P = 0.153) annually. The regression interaction term showed within-patient ferritin increases over time were independently associated with escalating AST and ALT (P < 0.05), after adjusting for confounders. Conclusion: Rising ferritin levels predict progressive liver injury in regularly transfused pediatric thalassemia patients. Tighter control of iron overload may help preserve hepatic function.
Automated Field-of-View, Illumination, and Recognition Algorithm Design of a Vision System for Pick-and-Place Considering Colour Information in Illumination and Images

Yibing Chen,T. Ogata,T. Ueyama,Toshiyuki Takada,J. Ota

DOI: https://doi.org/10.3390/s18051656

2018-05-01

Abstract:Machine vision is playing an increasingly important role in industrial applications, and the automated design of image recognition systems has been a subject of intense research. This study has proposed a system for automatically designing the field-of-view (FOV) of a camera, the illumination strength and the parameters in a recognition algorithm. We formulated the design problem as an optimisation problem and used an experiment based on a hierarchical algorithm to solve it. The evaluation experiments using translucent plastics objects showed that the use of the proposed system resulted in an effective solution with a wide FOV, recognition of all objects and 0.32 mm and 0.4° maximal positional and angular errors when all the RGB (red, green and blue) for illumination and R channel image for recognition were used. Though all the RGB illumination and grey scale images also provided recognition of all the objects, only a narrow FOV was selected. Moreover, full recognition was not achieved by using only G illumination and a grey-scale image. The results showed that the proposed method can automatically design the FOV, illumination and parameters in the recognition algorithm and that tuning all the RGB illumination is desirable even when single-channel or grey-scale images are used for recognition.
Role of Transient Elastography in Pediatric Transfusion Dependent Thalassemia Patients from Lower Socioeconomic Strata and its Correlation with Serum Ferritin: A Cross-Sectional Study

Shambhavi,Kumar Shwetanshu Narayan,Ananya Ghosh,Olie Mitra,Pawan Kumar Dubey,Mrinal Manjari,Ujjawal Sahay

DOI: https://doi.org/10.1007/s12288-024-01906-8

2024-10-30

Indian Journal of Hematology and Blood Transfusion

Abstract:Thalassemia is a very common single gene disorder worldwide. They regularly require blood transfusions resulting in excessive accumulation of iron in various organs. The liver is the first organ to accumulate iron and this excessive iron leads to hepatic fibrosis. Data regarding prevalence of hepatic fibrosis in children is lacking. Transient elastography (TE) is a recent non-invasive test to estimate liver-stiffness. Its role in children with thalassemia has not been fully investigated. We aimed to see the prevalence of hepatic fibrosis in transfusion dependent thalassemia (TDT) patients belonging to lower socioeconomic-strata and correlate the degree of hepatic fibrosis with serum ferritin. This cross-sectional study was conducted in July 2023 in tertiary care hospital in TDT children from lower socio-economic strata, aged 3–13 years who were negative for Hepatitis C and B. Blood investigations and TE were conducted in all the included patients and statistical analysis was done. 45 patients fulfilled inclusion and exclusion criteria. Mean age was 6 years, Mean serum ferritin was 2010.2 ng/ml, mean Liver stiffness Measurement (LSM) score was 9.25 kPa. 51.1% of study subjects had varying degree of hepatic fibrosis. We found significant positive correlation between serum ferritin and LSM score. We conclude that prevalence of hepatic fibrosis is high in TDT children and TE can be used to monitor hepatic fibrosis in this vulnerable group of patients.

hematology
The Course of Hepatitis C Infection and Response to Anti-viral Therapy in Patients with Thalassemia major and Hepatitis C Infection: A Longitudinal, Prospective Study

Sanaa Kamal,Sara Abdelhakam,Dalia Ghoraba,Mohamed Amer Mohsen,Ahmed Abdel Salam,Hoda Hassan,Leila Nabeigh

DOI: https://doi.org/10.4084/MJHID.2019.060

2019-11-01

Abstract:Background: The course of hepatitis C infection (HCV) in patients with thalassemia has not been adequately studied, and management has not been optimized. The current prospective longitudinal study assessed the clinical course, outcome, progression, and management of recently acquired HCV in patients with transfusion-dependent thalassemia major versus acute HCV without thalassemia. Methods: A well-characterized cohort of patients with thalassemia and recent HCV infection or recent HCV without thalassemia were enrolled and prospectively followed. The blood transfusion needs and chelating agents were determined. Liver functions tests, HCV-RNA, iron, and ferritin levels were measured. Patients with chronic HCV evolution received treatment for HCV. The fibrosis progression rate was determined in chronic HCV patients with or without thalassemia by paired liver biopsies or serial transient elastography (TE), or serum markers of liver fibrosis. Liver iron content (LIC) was assessed by R2 MRI. Results: Self-limited acute HCV was observed in 17% of patients with acute HCV and thalassemia versus 35% of patients without thalassemia (P=0.031). The fibrosis progression rates were significantly higher in patients with chronic HCV and thalassemia compared to those with chronic HCV alone (1.14±0.48) and (0.35±0.14) (P<0.0001), respectively. A direct linear correlation was observed between the fibrosis progression rate and each of LIC (R=+0.67; P=0.01) and ferritin (R=0.77; P<0.01). In patients with chronic HCV and thalassemia, the sustained virologic response (SVR) to pegylated interferon-based therapy and direct antiviral agents (DAAS) were 33% and 82% respectively (P<0.0001), while in chronic HCV patients without thalassemia, the SVR rates to PEG-IFN/RBV and DAAs were 51% and 92% respectively. Five patients with concomitant HCV and thalassemia died during the study due to cardiac causes (n=3) and liver cancer (n=2). Conclusions: Patients with acute HCV and thalassemia have low rates of spontaneous resolution of HCV infection, and the majority develop chronic HCV. Direct-acting antiviral combinations are associated with high SVR rates and low adverse event in treatment naïve and experienced patients with chronic HCV and thalassemia. Liver fibrosis is accelerated in thalassemia patients with chronic HCV; therefore, early diagnosis, treatment with DAAs, adequate iron chelation, and non-invasive monitoring liver status are recommended to prevent cirrhosis and hepatocellular carcinoma.
Noninvasive assessment and risk factors of liver fibrosis in patients with thalassemia major using shear wave elastography

Murtadha Al-Khabori,Shahina Daar,Said A Al-Busafi,Humoud Al-Dhuhli,AlGhalya A Alumairi,Moez Hassan,Sara Al-Rahbi,Umaima Al-Ajmi

DOI: https://doi.org/10.1080/10245332.2018.1540518

IF: 2.264

Hematology

Abstract:Objectives: This study aimed to estimate the prevalence of liver fibrosis and assess the risk factors for developing significant liver fibrosis in patients with Thalassemia Major (TM). Methods: All patients with TM over the age of 10 years were included in the study. Results: A total of 94 eligible patients underwent 2-D SWE. The median age was 26.7 years. The median of the average 5-year serum ferritin (5yrSF) and liver iron concentration (LIC) assessed by MRI T2* were 1326 µg/L and 6.7 mg/g dw, respectively. Hepatitis C and hepatitis B core antibodies were positive in 38% and 1% of the patients respectively. The proportion of patients with significant fibrosis was 60%. Male gender increased the risk of significant fibrosis (Odds ratio of 0.4; p = .0373). Additionally, the 5yrSF (p = .00661), the LIC (p = .0225) and the lowest LIC of the previous 5 years (p = .0211) were significant. In the multivariable logistic regression model, only 5yrSF (p = .0035) and gender (p = .00984) remained significant. Conclusions: The risk of liver fibrosis is associated with iron overload and gender in patients with TM.
Glucose tolerance in patients with oral symptoms.

H. Chinn,H. Brody,S. Silverman,V. DiRaimondo

Abstract:
Transient Elastography of Liver and Serum Hyaluronic Acid Levels In Adult Transfusion Dependent Thalassemia Patients

Varuna Yadav,Shubha Laxmi Margekar,Aparna Agrawal,Anupam Prakash

Abstract:Iron overload occurs as a result of multiple blood transfusions and increased iron absorption in thalassemia patients. Iron deposition in liver results in liver stiffness and fibrosis. Non invasive methods including imaging and serum biomarkers have been introduced for assessment of liver fibrosis. We aimed to study liver stiffness using transient elastography and serum hyaluronic acid levels and correlate them with serum ferritin levels in adult transfusion dependent beta thalassemia patients. Material: 70 transfusion dependent thalassemia patients of age ≥18 years, registered at Thalassemia Day Care Centre were subjected to investigations like CBC, Liver function tests, viral markers, serum ferritin, serum hyaluronic acid levels and transient elastography. Fibrosis indices like FIB-4, AAR and APRI were also calculated. 45 patients had T2*MRI reports with them; which were also included and analysed. Spearman coefficient r was used to test correlations between TE values and serum HA levels with other variables. Observation: 70 patients (41 male and 29 female) with mean age of 24.09±5.38 years and BMI 20.51 ±3.47 kg/m², were enrolled. Median values of hemoglobin, AST, ALT, TE, serum HA and serum ferritin were, 9.15 g/dl, 42 IU/L, 47.50 IU/L, 9.1 kPa, 284 ng/dl and 1841 ng/ml, respectively . TE values had significant positive correlation with serum ferritin (r=0.5, p < 0.001), ALT (r=0.59, p < 0.001), AST (r=0.58, p< 0.001), APRI (r=0.5, p<0.001) and FIB-4 (p=0.02), respectively and significant negative correlation with T2* MRI (ms) (r= -0.5, p<0.001). No significant correlation of HA was found with any variable. Conclusion: Transient elastography can be used as a non expensive, easily accessible and non invasive marker of liver iron overload. Further detailed studies are required to establish the role of serum Hyaluronic acid in thalassemia patients.
Bound sugars in hepatic glycoproteins from male rats during early protein depletion.

N. Wood,L. Fillios

DOI: https://doi.org/10.1093/JN/110.2.324

1980-02-01

Abstract:
MRI Evaluation of Liver and Cardiac Iron Overload Impact on Hematopoietic Stem Cell Transplantation with β-Thalassemia Major

Libai Chen,Yuelin He,Jianyun Wen,Wenjing Yang,Xuan Liu,Yongsheng Ruan,Xiaoqin Feng,Chunfu Li,Xuedong Wu

DOI: https://doi.org/10.1182/blood-2019-128903

IF: 20.3

2019-11-13

Blood

Abstract:OBJECTIVE: To assess the effects of liver and cardiac iron overload detected by magnetic resonance imaging (MRI) T2* on hematopoietic stem cell transplantation in children with β-thalassemia major. METHODS:Summary of 380 cases of β-thalassemia major patients more than 5 years old in Nanfang hospital, southern medical university from 2012 to 2019.Iron concentrations in the liver and heart were calculated based on MRI T2* test results of liver and heart. Age, serum ferritin, left ventricular ejection fraction (LVEF), and liver function were compared to evaluate the effect of iron overload on organ function in patients with β-thalassemia major before transplantation.168 patients underwent allogeneic hematopoietic stem cell transplantation, 48 were HLA-mismatched transplantation, and 120 were HLA-identical allogeneic hematopoietic stem cell transplantation.To analysis the influence between implantation rate, hematopoietic reconstruction time, mortality, and common complications after transplantation such as graft-versus-host disease, hepatic venous obstruction, infection, immune hemolysis, and pancytopenia and liver and cardiac iron overload detected by magnetic resonance imaging (MRI) T2*. RESULTS:Myocardial iron overload occurred in 73 cases (19.2%), including 29 cases of cardiac T2*15~20 ms (mild), 23 cases of 10~14 ms (moderate), and 21 cases of <10 ms (severe).There were 305 cases (80.2%) with liver iron overload, including 98 cases with 2.7~6.3 ms (mild), 166 cases with 1.4~2.7 ms (moderate), and 41 cases with <1.4 ms (severe).LVEF decreased in 5 cases (1.6%).Liver iron was positively correlated with serum ferritin (r=0.523, P=0.001), cardiac iron concentration was positively correlated with serum ferritin (r=0.33, P=0.1), age was positively correlated with cardiac iron concentration (r=0.4, P=0.14), and age was negatively correlated with left ventricular ejection fraction (r=-0.36, P=0.001).After transplantation, liver iron concentration was positively correlated with hemoglobin implantation time (r=0.49, P=0.043), heart iron concentration was positively correlated with mortality (r=0.39, P=0.012), serum ferritin was negatively correlated with implantation rate (r=-0.26, P=0.012), and serum ferritin was positively correlated with infection incidence correlation (r=0.441, P=0.034).There were no statistically significant differences in liver, heart MRI T2*, liver iron concentration and heart iron concentration between the two groups before and after transplantation. CONCLUSION:Magnetic resonance imaging (T2*) is an effective and non-invasive method to detect the iron overload in the heart and liver caused by blood transfusion in β-thalassemia patients. Iron overload can have adverse effects on hematopoietic stem cell transplantation,and effective iron removal before transplantation can improve the success rate of transplantation.Quantitative assessment of iron overload in the liver and heart by MRI can be used as a necessary examination before transplantation. Disclosures No relevant conflicts of interest to declare.

hematology
Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major

Stella Santarone,Stefano Angelini,Annalisa Natale,Doriana Vaddinelli,Raffaele Spadano,Paola Casciani,Franco Papola,Enza Di Lembo,Giovanni Iannetti,Paolo Di Bartolomeo

DOI: https://doi.org/10.1038/s41409-022-01786-4

Abstract:In this retrospective study, we evaluated long-term survival and late effects in 137 patients affected by thalassemia major (TM) who received an allogeneic hematopoietic cell transplantation (HCT). Median age at HCT was 10.1 years. After a median follow-up of 30 years, 114 (83.2%) patients are living and 108 (78.8%) are cured. The cumulative incidence of nonrelapse mortality and thalassemia recurrence was 9.5% at 1 year and 10.2% at 39 years respectively. The 39-years cumulative incidence of overall survival and disease-free survival were 81.4% and 74.5%. One hundred twenty-three patients who survived more than 2 years after HCT were evaluated for late effects concerning hematological disorders, iron burden, growth, obesity, diabetes mellitus, thyroid and gonadal function, eye, heart, liver, lung, kidney, gastrointestinal, neurologic and psychiatric system, osteoarticular system, secondary solid cancer (SSC), performance status, and Covid-19 infection. Fertility was preserved in 21 males whose partners delivered 34 neonates and 25 females who delivered 26 neonates. Fifteen cases of SSC were diagnosed for a 39-year cumulative incidence of 16.4%. HCT represents a definitive cure for the majority of TM patients at the price, however, of a non-negligible early and late mortality which in the long run affects survival and disease-free survival.
[Psychiatry and mental health in Morocco].

D. Moussaoui

DOI: https://doi.org/10.1016/S0001-4079(19)33013-4

2007-04-01

Abstract:
Liver steatosis in patients with transfusion‐dependent thalassaemia

Paolo Ricchi,Laura Pistoia,Vincenzo Positano,Anna Spasiano,Tommaso Casini,Maria Caterina Putti,Zelia Borsellino,Antonella Cossu,Giuseppe Messina,Petra Keilberg,Carmina Fatigati,Silvia Costantini,Stefania Renne,Giuseppe Peritore,Filippo Cademartiri,Antonella Meloni

DOI: https://doi.org/10.1111/bjh.19496

2024-05-01

British Journal of Haematology

Abstract:Hepatic fat fraction is significantly higher in transfusion‐dependent thalassaemia (TDT) patients than in healthy subjects. In TDT, liver steatosis is a frequent finding, associated with iron overload, increased body weight and hepatitis C virus (HCV) infection, and conveying an increased risk for the alterations of glucose metabolism. Summary We evaluated the prevalence and the clinical associations of liver steatosis (LS) in patients with transfusion‐dependent thalassaemia (TDT). We considered 301 TDT patients (177 females, median age = 40.61 years) enrolled in the Extension‐Myocardial Iron Overload in Thalassaemia Network, and 25 healthy subjects. Magnetic resonance imaging was used to quantify iron overload and hepatic fat fraction (FF) by T2* technique and cardiac function by cine images. The glucose metabolism was assessed by the oral glucose tolerance test (OGTT). Hepatic FF was significantly higher in TDT patients than in healthy subjects (median value: 1.48% vs. 0.55%; p = 0.013). In TDT, hepatic FF was not associated with age, gender, serum ferritin levels or liver function parameters, but showed a weak inverse correlation with high‐density lipoprotein cholesterol. The 36.4% of TDT patients showed LS (FF >3.7%). Active hepatitis C virus (HCV) infection, increased body mass index and hepatic iron were independent determinants of LS. A hepatic FF >3.53% predicted the presence of an abnormal OGTT. Hepatic FF was not correlated with cardiac iron, biventricular volumes or ejection fractions, but was correlated with left ventricular mass index. In TDT, LS is a frequent finding, associated with iron overload, increased weight and HCV, and conveying an increased risk for the alterations of glucose metabolism.

hematology
Proceedings of the Seventh International Workshop on Computing Education Research, ICER 2011, Providence, RI, USA, August 8-9, 2011

M. Caspersen,M. Clancy,Kathryn E. Sanders

Abstract:
Single-crystalline molybdenum trioxide nanoribbons: photocatalytic, photoconductive, and electrochemical properties.

Liang Cheng,Mingwang Shao,Xiuhua Wang,Haibo Hu

DOI: https://doi.org/10.1002/chem.200802182

2009-02-23

Chemistry

Abstract:Large-scale, high-purity and uniform alpha-MoO(3) nanoribbons have been synthesized by a facile hydrothermal route without employing surfactants or templates. The as-prepared alpha-MoO(3) nanoribbons were up to several micrometers in length, 100 nm in width, 15-20 nm in thickness, and grew along the [001] direction. The obtained nanoribbons exhibited a quantum size effect in optical properties, showing a blue shift of the band gap and direct transitions compared with the values of bulk MoO(3). The nanoribbons also showed superior photocatalytic ability in the photodegradation reaction of an aqueous solution of Rhodamine B under visible light. Furthermore, the as-prepared alpha-MoO(3) materials exhibited linear current-voltage (I-V) characteristics and excellent photoresponse. As the light source was switched on and off, the currents could be reversibly switched between high and low value at the voltage of 0.1 V. Electrochemical measurements predicted that the alpha-MoO(3)/carbon fiber modified microelectrode would display excellent electrochemical characters and high sensitivity toward neurotransmitter dopamine. The modified electrode was also quite stable and had good reproducibility, which might have application in the electrochemical analysis.

Weight at birth and other factors influencing progression of idiopathic membranous nephropathy.

Iron Metabolism Before Allo-Hsct in Patients with Acute Leukemia and Impact of Iron Overload on Transplantation

Serem Ferritin Was the Only Prognostic Factor for Disease Free Survival in Mds Patients after Allo-Hsct: A Single Centre Study

Hepatic iron overload and fibrosis in patients with beta thalassemia major after hematopoietic stem cell transplantation: A pilot study

Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT)

The effect of bone marrow-derived mesenchymal stem cell co-transplantation with hematopoietic stem cells on liver fibrosis alleviation and survival in patients with class III β-thalassemia major

Association between Transfusion-Related Iron Overload and Liver Fibrosis in Survivors of Pediatric Leukemia: A Cross-Sectional Study

Association of serum ferritin trends with liver enzyme patterns in β-thalassemia major: A longitudinal correlational study

Automated Field-of-View, Illumination, and Recognition Algorithm Design of a Vision System for Pick-and-Place Considering Colour Information in Illumination and Images

Role of Transient Elastography in Pediatric Transfusion Dependent Thalassemia Patients from Lower Socioeconomic Strata and its Correlation with Serum Ferritin: A Cross-Sectional Study

The Course of Hepatitis C Infection and Response to Anti-viral Therapy in Patients with Thalassemia major and Hepatitis C Infection: A Longitudinal, Prospective Study

Noninvasive assessment and risk factors of liver fibrosis in patients with thalassemia major using shear wave elastography

Glucose tolerance in patients with oral symptoms.

Transient Elastography of Liver and Serum Hyaluronic Acid Levels In Adult Transfusion Dependent Thalassemia Patients

Bound sugars in hepatic glycoproteins from male rats during early protein depletion.

MRI Evaluation of Liver and Cardiac Iron Overload Impact on Hematopoietic Stem Cell Transplantation with β-Thalassemia Major

Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major

[Psychiatry and mental health in Morocco].

Liver steatosis in patients with transfusion‐dependent thalassaemia

Proceedings of the Seventh International Workshop on Computing Education Research, ICER 2011, Providence, RI, USA, August 8-9, 2011

Single-crystalline molybdenum trioxide nanoribbons: photocatalytic, photoconductive, and electrochemical properties.